SCHEMBL31051471

SCHEMBL31051471

Cl[13c]1[13cH][13c](Cl)ncn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28153591 0.96 MEN1 (0.40) —
Methylene Chloride SCHEMBL27947432 0.90 MEN1 (0.38) —
SCHEMBL29136970 0.83 KMO (0.44) —
Acetaldehyde SCHEMBL28232456 0.83 NPC1 (0.35) —
Isopropyl Alcohol SCHEMBL28207243 0.83 NPC1 (0.35) —
Chlorobenzene SCHEMBL27930649 0.81 TSHR (0.55) —
Bicarbonate SCHEMBL28202844 0.81 KMO (0.33) —
SCHEMBL4146204 0.78 — —
SCHEMBL9970864 0.78 — —
SCHEMBL1851665 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12275728-B2 O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors BIOGEN MA INC. (US) 2025-04-15 — — US disclosed
US-12180205-B2 O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors BIOGEN MA INC. (US) 2024-12-31 — — US disclosed
US-20240308995-A1 O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLUCOPYRANOSIDASE INHIBITORS BIOGEN MA INC. 2024-09-19 — — US disclosed
CN-113166137-B O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranoside enzyme inhibitors 比奥根MA公司 2024-08-16 — — CN disclosed
Send feedback